Data gathered: November 23
AI Stock Analysis - Evotec (EVO)
Analysis generated October 29, 2024. Powered by Chat GPT.
Evotec SE is a Germany-based drug discovery alliance and development partnership company focused on leveraging its expertise to provide solutions to the pharmaceutical industry. The company operates through two major segments: EVT Execute and EVT Innovate, aimed at offering a diversified portfolio of services and products. With strong alliances with pharmaceutical and biotech companies, Evotec aims to accelerate drug discovery and development processes.
Stock Alerts - Evotec (EVO)
 |
Evotec | November 22 Price is down by -16.3% in the last 24h. |
|
Evotec | November 19 Price is down by -9.7% in the last 24h. |
|
Evotec | November 15 Price is up by 7.4% in the last 24h. |
|
Evotec | November 14 Price is up by 9.9% in the last 24h. |
Alternative Data for Evotec
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 52 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 61,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 43 | Sign up | Sign up | Sign up |
| Patents | 1 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 83 | Sign up | Sign up | Sign up |
| Twitter Followers | 4,185 | Sign up | Sign up | Sign up |
| Twitter Mentions | 31 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 430 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 64 | Sign up | Sign up | Sign up |
| Business Outlook | 21 | Sign up | Sign up | Sign up |
| Linkedin Employees | 4,986 | Sign up | Sign up | Sign up |
About Evotec
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.
| Price | $4.49 |
| Target Price | Sign up |
| Volume | 633,300 |
| Market Cap | $1.7B |
| Year Range | $2.9 - $7.87 |
| Dividend Yield | 0% |
| Analyst Rating | 67% buy |
| Industry | Drug Manufacturers |
In the news
 |
Halozyme Withdraws Evotec Bid After Rebuff, Reaffirms Strong Growth OutlookNovember 22 - Yahoo |
 |
Halozyme shares jump 12% as it scraps $2.1 bln Evotec dealNovember 21 - Yahoo |
|
Halozyme withdraws $2.1 billion buyout offer for German drug developer EvotecNovember 21 - Yahoo |
 |
Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in DiscussionsNovember 21 - Yahoo |
 |
Halozyme drops Evotec buyout bid; Patient dies in Neurogene trialNovember 21 - Yahoo |
 |
Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec DealNovember 19 - SeekingAlpha |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 185M | 167M | 18M | -40M | -45M | -0.120 |
| Q2 '24 | 182M | 166M | 16M | -95M | -102M | -0.288 |
| Q1 '24 | 209M | 174M | 35M | -21M | -16M | -0.060 |
| Q4 '23 | 201M | 164M | 38M | -16M | -23M | -0.050 |
| Q3 '23 | 196M | 158M | 38M | -39M | -9.8M | -0.120 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$155.17 0% | 51 |
 |
Eli Lilly and CompanyLLY |
$748.01 0% | 64 |
 |
PfizerPFE |
$25.65 0% | 47 |
 |
AstrazenecaAZN |
$65.63 0% | 71 |
 |
AbbVieABBV |
$176.95 0% | 59 |
Read more about Evotec (EVO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Evotec?
The Market Cap of Evotec is $1.7B.
What is the current stock price of Evotec?
Currently, the price of one share of Evotec stock is $4.49.
How can I analyze the EVO stock price chart for investment decisions?
The EVO stock price chart above provides a comprehensive visual representation of Evotec's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Evotec shares. Our platform offers an up-to-date EVO stock price chart, along with technical data analysis and alternative data insights.
Does EVO offer dividends to its shareholders?
As of our latest update, Evotec (EVO) does not offer dividends to its shareholders. Investors interested in Evotec should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Evotec?
Some of the similar stocks of Evotec are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.